Popular Articles

Japan's Cases Of New H1N1 Flu Surge Over Weekend
The number of confirmed cases of new A/H1N1 swine flu in Japan surged over the weekend, when health officials reported earlier today,

In Parkinson's Fly Model, Dementia Induced And Blocked
Parkinson"s disease is well-known for impairing movement and causing tremors, but many patients also develop other serious problems, including sleep disturbances and significant losses in cognitive function known as dementia.
News of the day
Terminally Ill Patients And Their Physicians Delay Conversations About End-of-Life Choices, Study Finds
About half of terminally ill patients do not have discussions with their physicians regarding end-of-life choices, according to a Harvard Medical School study published in the Archives of Internal Medicine, the Boston Globe reports.The study, funded by the National Cancer Institute, examined files on 1,517 patients in California, Iowa and Alabama with metastasized lung cancer. According to the Globe, a majority of patients diagnosed with metastasized lung cancer do not survive two years. Researchers asked the patients whether a physician or other health care provider had recommended hospice care or discussed end-of-life care preferences with them. According to the study, about 49% of blacks and 43% of Hispanics had discussed end-of-life care preferences with a physician or health care provider within four to seven months of their diagnosis, compared with 53% of whites and 57% of Asians. Lead study author Haiden Huskamp, an associate professor at Harvard Medical School, said, "Patients who had unrealistic expectations about how long they had to live were much less likely to talk about hospice with their doctor." Huskamp theorized that patients who said they did not discuss end-of-life options with providers might not have completely understood their prognosis or chose to believe in a better outcome. Huskamp also said physicians typically are not well-trained to handle some delicate conversations (Lazar, Boston Globe, 5/26).
Medical Devices

Doctor Testifies About Botched Prostate Treatment At VA Hospital

Dr. Gary D. Kao testified Monday about botched prostate cancer treatment he gave to patients at a Veterans Affairs hospital run by the University of Pennsylvania. The New York Times reports: "The radiation oncologist whom regulators accuse of mishandling scores of radioactive seed implants at the Philadelphia veterans" hospital told a Congressional panel on Monday that while he "could have done better" with some implants, his patients over all received effective treatment for their prostrate cancer." The New York Times reports that Kao "said he was voluntarily appearing before the committee, led by Senator Arlen Spector Democrat of Pennsylvania, to "correct some very serious false allegations in recent publications about me, most notably The New York Times." The Times reported last week that investigators for the Nuclear Regulatory Commission and V.A. officials had identified Dr. Kao as the doctor who did all but a handful of what they said were 92 substandard seed implants out of 116 cases over more than six years. In some cases, most of the tiny metal seeds ended up in other organs. An N.R.C. consultant reviewed about a quarter of the flawed implants and concluded that "erratic seed placement caused a number of cases to have elevated doses to the rectum, bladder or perineum." The Times"s examination of the prostate cancer unit at the hospital also found that the errors resulted from a systemwide regulatory failure, in which none of the safeguards intended to protect veterans from poor medical care had worked" (Bogdanich, 6/29). This information was reprinted from kaiserhealthnews.org with kind permission from the Henry J. Kaiser Family Foundation. You can view the entire Kaiser Daily Health Policy Report, search the archives and sign up for email delivery at kaiserhealthnews.org. © Henry J. Kaiser Family Foundation. All rights reserved.


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):